Profile - To The Moon

shirleytai

Posts · 2Posts · 2
Following · 0Following · 0
Followers · 0Followers · 0

- shirleytaishirleytai
  ·2021-07-07
  ?
  Sorry, this post has been deleted
  1.77K Comment
  1
  Share
  Report
- shirleytaishirleytai
  ·2021-07-06
  ??
  Chaoju Ophthalmology's first-hand winning rate was 5.67%, and the subscription of 18 lots was stable
  7月6日，朝聚眼科发布公告，公司全球发售1.7093亿股股份，其中香港发售股份8546.5万股，国际发售股份8546.5万股，另有15%超额配股权；发售价已厘定为每股发售股份10.60港元，每手买卖单
  Chaoju Ophthalmology's first-hand winning rate was 5.67%, and the subscription of 18 lots was stable
  1.35K Comment
  4
  Share
  Report

Most Discussed

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"3583996007556296","uuid":"3583996007556296","gmtCreate":1621427119474,"gmtModify":1625538654122,"name":"shirleytai","pinyin":"shirleytai","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/a62eeaa9b082fb7921a99c1523086d86","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":1,"tweetSize":2,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.67%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":140410868,"gmtCreate":1625668409654,"gmtModify":1703746106896,"author":{"id":"3583996007556296","authorId":"3583996007556296","name":"shirleytai","avatar":"https://static.tigerbbs.com/a62eeaa9b082fb7921a99c1523086d86","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583996007556296","idStr":"3583996007556296"},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/140410868","repostId":"1186984060","repostType":4,"isVote":1,"tweetType":1,"viewCount":1769,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":154493285,"gmtCreate":1625537342547,"gmtModify":1703743255510,"author":{"id":"3583996007556296","authorId":"3583996007556296","name":"shirleytai","avatar":"https://static.tigerbbs.com/a62eeaa9b082fb7921a99c1523086d86","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583996007556296","idStr":"3583996007556296"},"themes":[],"htmlText":"??","listText":"??","text":"??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/154493285","repostId":"1165762531","repostType":4,"repost":{"id":"1165762531","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1625527248,"share":"https://ttm.financial/m/news/1165762531?lang=en_US&edition=fundamental","pubTime":"2021-07-06 07:20","market":"hk","language":"zh","title":"Chaoju Ophthalmology's first-hand winning rate was 5.67%, and the subscription of 18 lots was stable","url":"https://stock-news.laohu8.com/highlight/detail?id=1165762531","media":"老虎资讯综合","summary":"7月6日，朝聚眼科发布公告，公司全球发售1.7093亿股股份，其中香港发售股份8546.5万股，国际发售股份8546.5万股，另有15%超额配股权；发售价已厘定为每股发售股份10.60港元，每手买卖单","content":"<p>On July 6,<a href=\"https://laohu8.com/S/02219\">Chaoju Ophthalmology</a>Announced that the company offered 170.93 million shares globally, including 85.465 million shares offered in Hong Kong, 85.465 million shares offered internationally, and 15% over-allotment option; The Offer Price has been determined at HK$10.60 per Offer Share for board lot of 500 Shares;<a href=\"https://laohu8.com/S/00665\">Haitong International</a>and Huatai International as a joint sponsor, it is expected that the Shares will be listed on the Main Board of the Stock Exchange on 7 July 2021.</p><p><b>The relevant data of Tiger Information are as follows:</b></p><p><img src=\"https://static.tigerbbs.com/6441c511f91e6e84af7887855b0edc92\" tg-width=\"1059\" tg-height=\"824\" referrerpolicy=\"no-referrer\"></p><p><b>Assignment Results:</b></p><p>Group A has 500 shares per lot, with a successful rate of 5.67%, and 18 subscriptions are stable.</p><p>Group B had 500,000 shares (1,000 lots) and was allocated 23,000 shares (46 lots).<img src=\"https://static.tigerbbs.com/c6d46a2302cf5f5cd13d74bd999ba571\" tg-width=\"551\" tg-height=\"433\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/22d1f538f9c2dfe684d9be93e828fe18\" tg-width=\"556\" tg-height=\"762\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/48b32d1999086d04329dfb7fa00773ce\" tg-width=\"553\" tg-height=\"520\" referrerpolicy=\"no-referrer\"></p><p>The Offer Shares initially offered under the International Offering have been significantly over-subscribed by approximately 17.83 times. The Offer Shares initially offered under the Hong Kong Public Offering have been very substantially over-subscribed. A total of 153,275 valid applications were received for a total of 1,948 million Shares, representing approximately 113.97 times the total number of Hong Kong Offer Shares initially available under the Hong Kong Public Offering.</p><p>Based on the Offer Price of HK$10.60 per Offer Share, pursuant to the Cornerstone Investment Agreement, the Cornerstone Investors have subscribed for a total of 74,674,500 Offer Shares, representing in aggregate approximately 10.86% of the issued share capital of the Company immediately following the completion of the Global Offering; and approximately 43.69% of the number of Offer Shares under the Global Offering (assuming the Over-allotment Option is not exercised).</p><p>Based on the latest estimates, based on the Offer Price of HK$10.60 per Offer Share, the net proceeds received by the Company from the Global Offering are estimated to be approximately HK$1,357.1 million (assuming the Over-allotment Option is not exercised). Among them, the company intends to use approximately 35.8% of the net proceeds for the establishment of new hospitals and the relocation, upgrading and decoration of existing hospitals; Approximately 44.8% will be used to acquire hospitals in new markets with large populations and relatively high demand for ophthalmic medical services when appropriate opportunities arise; About 9.4% will be used to upgrade the company's information technology systems; And approximately 10.0% will be used for working capital and other general corporate purposes.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chaoju Ophthalmology's first-hand winning rate was 5.67%, and the subscription of 18 lots was stable</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChaoju Ophthalmology's first-hand winning rate was 5.67%, and the subscription of 18 lots was stable\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time smaller\">2021-07-06 07:20</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>On July 6,<a href=\"https://laohu8.com/S/02219\">Chaoju Ophthalmology</a>Announced that the company offered 170.93 million shares globally, including 85.465 million shares offered in Hong Kong, 85.465 million shares offered internationally, and 15% over-allotment option; The Offer Price has been determined at HK$10.60 per Offer Share for board lot of 500 Shares;<a href=\"https://laohu8.com/S/00665\">Haitong International</a>and Huatai International as a joint sponsor, it is expected that the Shares will be listed on the Main Board of the Stock Exchange on 7 July 2021.</p><p><b>The relevant data of Tiger Information are as follows:</b></p><p><img src=\"https://static.tigerbbs.com/6441c511f91e6e84af7887855b0edc92\" tg-width=\"1059\" tg-height=\"824\" referrerpolicy=\"no-referrer\"></p><p><b>Assignment Results:</b></p><p>Group A has 500 shares per lot, with a successful rate of 5.67%, and 18 subscriptions are stable.</p><p>Group B had 500,000 shares (1,000 lots) and was allocated 23,000 shares (46 lots).<img src=\"https://static.tigerbbs.com/c6d46a2302cf5f5cd13d74bd999ba571\" tg-width=\"551\" tg-height=\"433\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/22d1f538f9c2dfe684d9be93e828fe18\" tg-width=\"556\" tg-height=\"762\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/48b32d1999086d04329dfb7fa00773ce\" tg-width=\"553\" tg-height=\"520\" referrerpolicy=\"no-referrer\"></p><p>The Offer Shares initially offered under the International Offering have been significantly over-subscribed by approximately 17.83 times. The Offer Shares initially offered under the Hong Kong Public Offering have been very substantially over-subscribed. A total of 153,275 valid applications were received for a total of 1,948 million Shares, representing approximately 113.97 times the total number of Hong Kong Offer Shares initially available under the Hong Kong Public Offering.</p><p>Based on the Offer Price of HK$10.60 per Offer Share, pursuant to the Cornerstone Investment Agreement, the Cornerstone Investors have subscribed for a total of 74,674,500 Offer Shares, representing in aggregate approximately 10.86% of the issued share capital of the Company immediately following the completion of the Global Offering; and approximately 43.69% of the number of Offer Shares under the Global Offering (assuming the Over-allotment Option is not exercised).</p><p>Based on the latest estimates, based on the Offer Price of HK$10.60 per Offer Share, the net proceeds received by the Company from the Global Offering are estimated to be approximately HK$1,357.1 million (assuming the Over-allotment Option is not exercised). Among them, the company intends to use approximately 35.8% of the net proceeds for the establishment of new hospitals and the relocation, upgrading and decoration of existing hospitals; Approximately 44.8% will be used to acquire hospitals in new markets with large populations and relatively high demand for ophthalmic medical services when appropriate opportunities arise; About 9.4% will be used to upgrade the company's information technology systems; And approximately 10.0% will be used for working capital and other general corporate purposes.</p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/6b69e234a63c2c0a69ccede7b0faaa18","relate_stocks":{"02219":"朝聚眼科"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1165762531","content_text":"7月6日，朝聚眼科发布公告，公司全球发售1.7093亿股股份，其中香港发售股份8546.5万股，国际发售股份8546.5万股，另有15%超额配股权；发售价已厘定为每股发售股份10.60港元，每手买卖单位500股；海通国际及华泰国际为联席保荐人，预期股份将于2021年7月7日于联交所主板挂牌上市。\n老虎资讯整理相关数据如下：\n\n分配结果：\n甲组每手500股，一手中签率5.67%，认购18手稳中一手。\n乙组头为50万股（1000手），获配23000股（46手）。\n根据国际发售初步提呈发售的发售股份已获大幅超额认购约17.83倍。根据香港公开发售初步提呈发售的发售股份已获非常大幅超额认购。合共接获153,275份有效申请，认购合共19.48亿股，相当于根据香港公开发售初步可供认购的香港发售股份总数约113.97倍。\n基于发售价每股发售股份10.60港元计算，根据基石投资协议，基石投资者已认购合共7467.45万股发售股份，合共占紧随全球发售完成后公司已发行股本约10.86%；及全球发售项下发售股份数目约43.69%(假设超额配股权未获行使)。\n基于发售价每股发售股份10.60港元计算，根据最新估计，公司自全球发售收取的所得款项净额估计约为13.571亿港元(假设超额配股权未获行使)。其中，公司拟将所得款项净额约35.8%将用于建立新医院以及搬迁、升级及装修现有医院；约44.8%将在出现合适机遇时，用于在人口庞大且对眼科医疗服务需求相对较高的新市场中收购医院；约9.4%将用于升级公司的信息技术系统；及约10.0%将用于营运资金及其他一般企业用途。","news_type":1,"symbols_score_info":{"02219":0.9}},"isVote":1,"tweetType":1,"viewCount":1348,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}